We are delighted to have recently started a new trial with the patientMpower platform for renal dialysis. Together with researchers in Beaumont Hospital, Dublin, Ireland, we are examining how the patientMpower app can help people undergoing renal dialysis to better manage their fluid weight gain between dialysis sessions. The trial protocol is available on clinicaltrials.gov.Read More
patientMpower is looking forward to attending the European Respiratory Society (ERS) Congress, which this year is being held in Paris from 15 – 19th September.Read More
We are delighted that our app for IPF has been recently been endorsed by the EU-IPFF.
The European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) is a non-profit organization that brings together European national patient associations committed to defending their vision of equal access to treatment and care for all IPF patients. They aim to serve as a trusted resource for the IPF community by raising awareness, providing disease education, advancing care, and supporting research for IPF whilst defending the interests of IPF patients at European level.
One of the measurements you can track on the patientMpower app is your oxygen saturation(SpO2), which is measured using a pulse oximeter. Not all people using the patientMpower app currently record their oxygen saturation on the platform, and you may therefore be interested to know more about this feature.Read More
We are pleased to announce the launch of the new caregiver, friends and family sharing tool for the patientMpower platform!Read More
patientMpower will be exhibiting at ATS 2018 and we would like to invite you to come and visit us to learn more about our specialist remote patient tracking platforms for Pulmonary Fibrosis and Lung Transplant.Read More
patientMpower is delighted to announce the release of our new platform; patientMpower for Lung Transplant.Read More
patientMpower for pulmonary fibrosis and lung transplant enables you to keep track of everything relating to your lung health, empowering you to get the best possible outcomes from your treatment and care. Our free app connects to devices you can use at home to track spirometry, pulse oximetry, medication reminders, air quality updates and step counter recording.Read More
Tell us about patientMpower in brief:
patientMpower is a digital healthcare company providing technology solutions for patients across a range of therapy areas including pulmonary fibrosis (IPF), renal dialysis and renal transplant. Our aim is to empower better outcomes by facilitating patients to better manage their care.
This week is pulmonary rehabilitation week!Read More
On behalf of patients across the UK living with Idiopathic Pulmonary Fibrosis (IPF), patientMpower expressed disappointment at NICE’s decision to restrict the use of the antifibrotic pirfenidone (Esbriet) to patients with moderate to severe forms of the disease. NICE recently issued final guidance that pirfenidone is recommended as a treatment option for IPF only if the patient has a forced vital capacity (FVC) between 50% and 80% predicted.Read More
Irish-based company awarded $333,333 in First-of-its-Kind Global Healthcare CompetitionRead More
Three Lakes Partners, a venture philanthropy committed to ending Idiopathic Pulmonary Fibrosis (IPF), named Advanced Interactive Response Systems (AIRS), Owlstone Medical and patientMpower the winners of its $1,000,000 IPF Catalyst Challenge last night during a live finalist pitch event at MATTER’s Chicago headquarters. Level Ex was honored with the event’s Audience Choice Award.Read More
Hello, my name is Colin Edwards and I’m from Dublin, Ireland. I am a scientist who wants to improve the outcome for people with idiopathic pulmonary fibrosis (IPF).Read More
patientMpower presented at the Artificial Intelligence Health2.0 Dublin chapter meetup hosted in January by Google and Verily. Eamonn Costello outlined the Machine Learning process patientMpower is employing in ‘cleaning’ and ‘training’ a real world spirometry data set. These data are contained within patientMpower’s “digital biobankTM“, which contains over 3 million Idiopathic Pulmonary Fibrosis (IPF) data points including thousands of Forced Vital Capacity (FVC) data points.Read More
patientMpower are excited to announce that they have been shortlisted as finalists in the $ 1 million IPF Catalyst Challenge.Read More
Many countries have different names for medicines, with brand names differing from USA to the UK for example. Currently we support USA, Canada, UK, Ireland, Australia, New Zealand, South Africa, Germany, Austria, Spain, Argentina.Read More